NASDAQ:MLTX | Free Cash Flow | MoonLake Immunotherapeutics

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$66.29M$0.00-$66.29M
2025-12-31-$58.79M$0.00-$58.79M
2025-03-31-$38.14M$35,000.00-$38.18M
2024-12-31-$48.47M$176,000.00-$48.65M
2024-03-31-$14.95M$212,000.00-$15.16M
2023-12-31-$12.34M$284,000.00-$12.63M
2023-03-31-$9.02M$0.00-$9.02M
2022-12-31-$11.6M$1.00-$11.6M
2022-03-31-$14.19M$16,010.00-$14.2M
2021-12-31$27.11M
2021-03-31-$107,795.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$196.01M$35,000.00-$196.04M
2024-12-31-$116.59M$520,000.00-$117.11M
2023-12-31-$42.78M$284,000.00-$43.06M
2022-12-31-$55.89M$16,009.00-$55.91M
2021-12-31-$611,071.00